Establishing the capability to take informed decisions with well-orchestrated GxP processes and unified communication will be a market differentiator for sponsors and affiliates. To proactively stay compliant with changing global GxP regulations, sponsors are increasingly working towards developing risk-based operational intelligence with integrated and insightful digital process management while working with multiple vendors, business partners, affiliates and service providers.

COMPIER - A Comprehensive Compliance, Competence & Collaboration Enabler Platform

Techsol GxP Process Management

Establish Digital Quality and Compliance Oversight

Compier is a purpose-built process orchestration and compliance governance solution to streamline, track and report the outcomes of GxP operations and related cross-functional activities managed by sponsors across different vendors, partners and affiliates.

Enable Lean GxP Operations and Maximize Productivity

The platform is engineered with modern technology to facilitate automation-driven process workflows and enables companies to take informed decisions using actionable insights.

With highly configurable modules, sponsors and service providers can opt for one or application modules in varying combinations according to their business need. The Compier SaaS subscription has a flexible pricing model benefiting organizations to scale-up operational efficiency.

Compier’s Pharmacovigilance Modules

Compier’s Clinical Development Modules

Key Platform Components

Following are few of the key platform components which enable operational oversight and compliance management across various GxP Operations:

  • Process Alerts & Notifications
  • Integrated Email Inbox
  • GxP Ops Business Intelligence Studio
  • Process Automation
  • Audit Trail & Utilities
  • Cross Functional System Integrations
  • Business Workflows
  • Digitalization of content
  • Collaboration on tasks and activities

Technology Image

How is Compier Delivered

  • Fast track system implementation with 4 system environments
  • Proprietary accelerators for rapid application configuration setup
  • Compier is pre-validated with IQ/OQ and is UAT ready
  • Expertise for setting up Compier system integrations & business reports
  • 24×7 Service Desk for Cloud and Application Support
  • Offered with 99.9% Cloud Availability & Disaster Recovery

Business Meeting

Is your organization planning to streamline and optimize your current GxP Operations through insights-driven regulatory compliant process automation? Send us a message and we will schedule a personalized platform demo aligned to your business needs.

Connect With Us To Schedule a Demo

    New Insights

    Best Practices for Signal Management in Pharmacovigilance

    Pharmacovigilance involves the collection, detection, assessment, and monitoring of data on Adverse Drug Reactions (ADRs) which must be evaluated to derive vital safety information. Signal detection involves monitoring the adverse reaction data for patterns that suggest new safety information. Safety signals can be detected from an extensive range of sources, such as spontaneous reports, clinical [...]

    Aggregate Reporting – Significance, Classification and Challenges

    Aggregate reports are the cumulative reports in the database that emphasise on evaluation of safety profile and risk-benefit analysis of a drug. Aggregate reporting is the process of compilation and submission of aggregate reports to the regulatory agencies over the period of the product’s life cycle (during pre-marketing and post-marketing phase) to provide a comprehensive [...]

    Literature Screening – Process overview, challenges en-route and the scope for automation

    Medical and scientific literature is a valuable source of safety information that helps in monitoring benefit-risk profiles and emerging safety issues of medicinal products. Literature screening is conducted to ascertain abstracts and articles that provide crucial information on serious and non-serious Individual Case Safety Reports (ICSR) reports and risk-benefit assessment of a drug. The scientific [...]